ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY

Kit, Test,alpha-fetoprotein For Testicular Cancer

BAYER CORP.

The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Acs:180 & Advia Centaur Afp Immunoassay.

Pre-market Notification Details

Device IDK020806
510k NumberK020806
Device Name:ACS:180 & ADVIA CENTAUR AFP IMMUNOASSAY
ClassificationKit, Test,alpha-fetoprotein For Testicular Cancer
Applicant BAYER CORP. 63 NORTH ST. Medfield,  MA  02052 -1688
ContactThomas F Flynn
CorrespondentThomas F Flynn
BAYER CORP. 63 NORTH ST. Medfield,  MA  02052 -1688
Product CodeLOJ  
CFR Regulation Number866.6010 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeSpecial
3rd Party ReviewedNo
Combination ProductNo
Date Received2002-03-12
Decision Date2002-03-27
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414598376 K020806 000
00630414598369 K020806 000
00630414294117 K020806 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.